From: Pelvic organ prolapse and uterine preservation: a cohort study (POP-UP study)
3 month follow-up N = 283 | 12 month follow-up N = 271 | |||||||
---|---|---|---|---|---|---|---|---|
Total N = 283 | Uterine sparing (LSH) N = 41 | Concomitant hysterectomy (LSCH + LSC & TLH + LSC) N = 242 | p | Total N = 271 | Uterine sparing (LSH) N = 38 | Concomitant hysterectomy (LSCH + LSC & TLH + LSC) N = 233 | p | |
Postoperative mesh complications [N/N] (%) | 2/283 (0.7%) | 0/41 (0.0%) | 2/242 (0.8%) | 1.000b | 4/271 (1.5%) | 1/38 (2.6%) | 3/233 (1.3%) | 0.456b |
Failure in apical compartment Point C ≥ -TVL/2 [N/N] (%) | 0/283 (0.0%) | 0/41 (0.0%) | 0/242 (0%) | – | 0/271 (0.0%) | 0/38 (0.0%) | 0/233 (0%) | – |
Failure in anterior compartment Point Ba ≥ 1 [N/N] (%) | 12/283 (4.2%) | 4/41 (9.8%) | 8/242 (3.3%) | 0.079b | 26/271 (9.6%) | 8/38 (21.1%) | 18/233 (7.7%) | 0.017b |
Failure in posterior compartment Point Bp ≥ -1 [N/N] (%) | 14/283 (4.9%) | 0/41 (0.0%) | 14/242 (5.8%) | 0.114b | 15/271 (5.5%) | 0/38 (0.0%) | 15/233 (6.4%) | 0.140b |
PGI-I 1, 2 [N/N] (%) | 243/283 (85.9%) | 35/41 (85.4%) | 208/242 (86.0%) | 0.607b | 255/271 (94.1%) | 33/38 (86.8%) | 222/233 (95.3%) | 0.055b |
PGI-I 3 [N/N] (%) | 28/283 (9.9%) | 4/41 (9.8%) | 24/242 (9.9%) | 11/271 (4.0%) | 3/38 (7.9%) | 8/233 (3.4%) | ||
PGI-I 4 [N/N] (%) | 8/283 (2.8%) | 1/41 (2.4%) | 7/242 (2.9%) | 4/271 (1.5%) | 2/38 (5.3%) | 2/233 (0.9%) | ||
PGI-I 5 [N/N] (%) | 2/283 (0.7%) | 1/41 (2.4%) | 1/242 (0.4%) | 1/271 (0.4%) | 0/38 (0.0%) | 1/233 (0.4%) | ||
PGI-I 6 [N/N] (%) | 2/283 (0.7%) | 0/41 (0.0%) | 2/242 (0.8%) | 0/271 (0.0%) | 0/38 (0.0%) | 0/233 (0%) | ||
PGI-I 7 [N/N] (%) | 0/286 (0.0%) | 0/41 (0.0%) | 0/242 (0%) | 0/271 (0.0%) | 0/38 (0.0%) | 0/233 (0%) | ||
Δ UDI pre-op – post-op [median (range)] | 20.1 (− 159 to 153) | 17.9 (− 54.9 to 131) | 20.1 (− 159 to 153) | 0.988a | 25.0 (− 112 to 160) | 17.6 (− 99 to 160) | 33.7 (− 112 to 150) | 0.585a |
Δ POPDI pre-op – post-op [median (range)] | 40.5 (− 112 to 256) | 35.7 (− 56 to 127) | 41.1 (− 112 to 256) | 0.559a | 39.3 (− 74 to 253) | 30.4 (− 43 to 135) | 48.2 (− 189 to 253) | 0.502a |
Δ CRADI pre-op – post-op [median (range)] | 7.7 (− 189 to 199) | 10.0 (− 41 to 129) | 7.1 (− 189 to 199) | 0.338a | 3.6 (− 92 to 170) | 10.7 (− 38 to 112) | 7.1 (− 118 to 170) | 0.187a |
Δ PFDI pre-op – post-op [median (range)] | 46.1 (− 342 to 450) | 50.7 (− 206 to 373) | 59.5 (− 343 to 450) | 0.889a | 70.4 (− 182 to 460) | 66.9 (− 123 to 281) | 82.5 (− 338 to 460) | 0.960a |